Predicting in vitro assays related to liver function using probabilistic machine learning
Flavio M Morelli1, Marian Raschke2, Natalia Jungmann2
1R&D Machine Learning Research, Bayer AG, Pharmaceuticals Division, Berlin, Germany; Department of Mathematics and Computer Science, Free University of Berlin, Berlin, Germany.
Abstract:
While machine learning has gained traction in toxicological assessments, the limited data availability requires the quantification of uncertainty of in silico predictions for reliable decision-making. This study addresses the challenge of predicting the outcome of in vitro assays associated with liver function by systematically comparing various probabilistic methods. Our research fills a critical gap by integrating multiple data modalities - chemical descriptors, gene expression, and morphological profiles - into a probabilistic framework aimed at predicting in vitro assays and quantifying uncertainty. We present a comprehensive evaluation of the performance of these data modalities and describe how this framework and the in vitro assay predictions can be integrated to estimate the probability of drug-induced liver injury (DILI) occurrence. Additionally, we contribute new experimental data for reactive oxygen species generation and hepatocyte toxicity assays, providing valuable resources for future research. Our findings underscore the importance of incorporating uncertainty quantification in toxicity predictions, potentially leading to a safer drug development process and reduced reliance on animal testing.
Related Concept Videos
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Drug Product Performance: In Vitro–In Vivo Correlation
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test


